Investigation of measurable residual disease in acute myeloid leukemia by DNA methylation patterns

Assessment of measurable residual disease (MRD) upon treatment of acute myeloid leukemia (AML) remains challenging. It is usually addressed by highly sensitive PCR- or sequencing-based screening of specific mutations, or by multiparametric flow cytometry. However, not all patients have suitable muta...

Descripción completa

Detalles Bibliográficos
Autores principales: Božić, Tanja, Kuo, Chao-Chung, Hapala, Jan, Franzen, Julia, Eipel, Monika, Platzbecker, Uwe, Kirschner, Martin, Beier, Fabian, Jost, Edgar, Thiede, Christian, Wagner, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727289/
https://www.ncbi.nlm.nih.gov/pubmed/34131280
http://dx.doi.org/10.1038/s41375-021-01316-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727289/
https://www.ncbi.nlm.nih.gov/pubmed/34131280
http://dx.doi.org/10.1038/s41375-021-01316-z

Ejemplares similares